Ixilka Biotech ©
@ixilka.bsky.social
Research Technologies
https://ixilka.net/
https://ixilka.net/
To test its functionality in the laboratory, we only need a saliva donor with this disease. If you know someone who has been diagnosed with this disease, please do not hesitate to contact us via the project email:
B-AxD2@ixilka.net
B-AxD2@ixilka.net
a group of children are holding a cardboard sign that says thanks .
ALT: a group of children are holding a cardboard sign that says thanks .
media.tenor.com
August 10, 2025 at 4:03 PM
To test its functionality in the laboratory, we only need a saliva donor with this disease. If you know someone who has been diagnosed with this disease, please do not hesitate to contact us via the project email:
B-AxD2@ixilka.net
B-AxD2@ixilka.net
This biomolecule is a BINDER (a hyper-specific protein-binding peptide) designed by CRAID (ixilka.net/craid/), that binds to the defective GFAP' molecule (and only to this molecule) so that it does not cause structural damage to neurons.
CRAID Methodology
ixilka.net
August 10, 2025 at 4:03 PM
This biomolecule is a BINDER (a hyper-specific protein-binding peptide) designed by CRAID (ixilka.net/craid/), that binds to the defective GFAP' molecule (and only to this molecule) so that it does not cause structural damage to neurons.